Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study.
- DOI
- 10.1016/j.phrs.2023.106949
- Published
- 2023 Nov
- Container
- Pharmacological research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.phrs.2023.106949,
title = {Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study.},
author = {Fragoulakis V and Roncato R and Bignucolo A and Patrinos GP and Toffoli G and Cecchin E and Mitropoulou C},
year = {2023},
journal = {Pharmacological research},
doi = {10.1016/j.phrs.2023.106949},
url = {https://doi.org/10.1016/j.phrs.2023.106949}
}RIS
TY - JOUR TI - Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study. AU - Fragoulakis V AU - Roncato R AU - Bignucolo A AU - Patrinos GP AU - Toffoli G AU - Cecchin E AU - Mitropoulou C PY - 2023 JO - Pharmacological research DO - 10.1016/j.phrs.2023.106949 UR - https://doi.org/10.1016/j.phrs.2023.106949 ER -
APA
V, F., R, R., A, B., GP, P., G, T., E, C., & C, M. (2023). Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study.. Pharmacological research. https://doi.org/10.1016/j.phrs.2023.106949
Source records
- pubmed · retrieved 2026-09-26T05:38:04.804Z